Fasting plasma triglyceride, plasma cholesterol and high-density lipoprotein (HDL) cholesterol levels were studied for 190 white women, ages 21-39 years, who were classified according to their oral contraceptive (OC) usage patterns at two community surveys, 3 years apart. The mean level of fasting triglyceride was higher among current OC users (95 mg/100 ml) than among nonusers (73 mg/100 ml) (p = 0.002). After adjustment for the possible confounding effects of age, weight, current cigarette smoking and fasting glucose level, current OC users still had a mean plasma triglyceride level 19 mg/100 ml higher than that of nonusers (p = 0.007). Current OC users also appeared to have somewhat higher levels of total cholesterol which were of borderline significance in crude and adjusted analyses. There was a nonsignificant inverse relationship of OC use with HDL cholesterol levels. Past use did not affect these results, indicating that the OC-induced lipid changes were reversible.
A THREE-TO-FIVEFOLD INCREASE in risk of myocardial infarction (MI) among current oral contraceptive (OC) users has been reported from two British case-control studies, one of deaths,1 and the other of survivors.2 This finding has also recently been reported from a case-control study of women in the United States. 3 The results of these retrospective studies are consistent with correlational data of OC use and mortality trends among women from 21 countries. 4 Initially, clinical5 and epidemiologic6 reports indicated that OC use promoted venous and arterial thromboembolism, suggesting an alteration in the coagulation mechanism which might account for the increased risk of MI among OC users. Recently, however, it has been suggested that the effect of OC use on risk of MI may be related to alterations in levels of major coronary risk factors .7 In this report we examine the relations of current and past OC use with fasting triglyceride, plasma cholesterol and high-density lipoprotein (HDL) cholesterol, as well as the confounding effects of additional variables.
Subjects and Methods Study Population
The present investigation examined a subgroup of middle-class white women aged [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] years, who had been classified according to their OC use at two community surveys performed in East Boston, Massachusetts in 1973 and 1976. Those eligible for inclusion were premenopausal, nonpregnant women aged 21-39 years, whose OC use had been characterized in 1973 and 1976. Of 286 women who fulfilled these criteria, 190 (70%) agreed to attend the study clinic after a 14-hour overnight fast.
Methods of Procedure
During each community survey, questionnaire information was obtained concerning cigarette smoking (yes or no), age, and stated body weight. In the clinic, fasting blood specimens were drawn by antecubital venipuncture with the women sitting. The specimens were collected between 8 and 10 a.m. in tubes that contained sodium EDTA. The tubes were inverted eight times and centrifuged, and the plasma was decanted. In addition, a fasting blood glucose was collected in a tube containing fluoride-oxalate, and measured by the glucose oxidase method. 8 Triglycerides were measured by a modification of the Kessler-Lederer method.9 Cholesterol concentrations in the total plasma were measured by the method of Abell-Kendall." HDL cholesterol fractions were separated by precipitating the other lipoproteins with heparin-manganese chloride, and measured by a modification of the method of Burstein and colleagues.1' These determinations were performed in the laboratory of the Framingham Heart Study, which participates in a quality-control program through a cooperative arrangement with the Lipid Research Clinics. 12 Initially, to evaluate the crude relationship between current OC use and each of the lipid fractions, the population was divided into those who did and those who did not use OCs in the 1976 survey. A t test was used to compare mean triglyceride, cholesterol and HDL cholesterol values for current (1976) users and nonusers.'3 In addition, current OC users were subdivided according to the composition of the OC preparation being used, and the levels of the three lipid fractions were compared for users of different preparations.
Current OC users and nonusers were then further classified according to OC use during the 1973 survey. A weighted mean difference between current OC users and nonusers was obtained by adjusting for past use, using as weights the inverse of the variance for each mean. 13 Finally, a multiple regression analysis13 was performed, incorporating as additional variables cigarette smoking, age, body weight and fasting glucose. These variables were entered into the regression equation one by one in descending order of strength of their association with the dependent variable, in this case the value for the particular lipid fraction (cholesterol, triglyceride or HDL cholesterol). For each fraction, the residual association with current OC use was evaluated by adding that variable to the significant predictors. Table 1 shows the mean + SD for fasting triglyceride, plasma cholesterol and HDL cholesterol among current (1976) OC users and nonusers. Among 86 current OC users, the mean fasting triglyceride level was significantly higher (p = 0.002) than that found among 104 nonusers. Total plasma cholesterol levels were also higher for current OC users than for nonusers, but the difference did not attain statistical significance (p = 0.08). HDL cholesterol values for current users were somewhat lower than those for nonusers (p = 0.08).
Results
Past (1973) OC use had no apparent effect on current (1976) levels of triglyceride, cholesterol or HDL cholesterol. The difference in triglyceride levels between current OC users and current nonusers was significant even after adjustment for past OC use. The nonsignificant elevation of total cholesterol in users as compared with nonusers was virtually unchanged by adjustment for past OC use, as was the small reduction in HDL cholesterol levels (table 2).
In the regression analysis for fasting triglycerides (table 3) , the significant variables were current smoking (p = 0.001) and current OC use (p = 0.007), the mean triglyceride levels for OC users being approximately 19 mg/100 ml higher than for nonusers. Table 4 shows that the variables associated with plasma cholesterol were age (p = 0.02), current smoking (p = 0.07) and current OC use (p = 0.06). HDL cholesterol levels (table 5) were inversely related to cigarette smoking (p < 0.001), weight (p = 0.003) and current OC use (p = 0.09). Table 6 shows the composition of the various OC preparations used by study participants. The mean values of triglycerides, total cholesterol and HDL cholesterol for users of the three most commonly taken preparations are compared in table 7. The mean triglyceride level was significantly higher for current users of norethindrone 1.0 mg with mestranol 0.05 mg (p = 0.01) and for users of norethindrone 1.0 mg with mestranol 0.08 mg (p = 0.04) compared with the level for nonusers. For users of norgestrel 0.5 mg with ethinyl estradiol 0.05 mg, HDL cholesterol was significantly lower (p < 0.001), while total plasma cholesterol was significantly higher (p = 0.007) than for nonusers. Discussion These data indicate a strongly positive association between current OC use and fasting triglyceride, a positive relationship of borderline significance with total plasma cholesterol, and a small and nonsignificant inverse effect on HDL cholesterol. These findings are consistent with those of recently reported cross-sectional studies;"4 15 the current study also evaluates effects of additional variables, namely, cigarette smoking, age, body weight and fasting blood glucose.
These findings are of particular interest in view of reports of increased risk of coronary heart disease among current OC users.`The increase in fasting triglyceride levels for current OC users suggests that a probable effect of OC use is to increase the level of very low density lipoproteins (VLDL). While triglyceride level (as a measure of VLDL) has not been shown to have an independent relationship with risk of coronary disease,16 a recent report from the Framingham study'7 suggests that in OC users, VLDL may be more triglyceride-enriched as well as increased. Whether this qualitative change in VLDL increases or decreases the atherogenic potential is unknown. Total plasma cholesterol has been shown to be a strong predictor of coronary risk, especially at younger ages.'6 The consistency and strength of this relationship suggest that OC-induced cholesterol elevations, although small, may at least partially explain the increased risk of MI.
The present data also showed a small, nonsignificant inverse relationship between OC use and HDL cholesterol. A recent report showed that different OC preparations had varying effects on HDL cholesterol. HDL cholesterol levels appeared to be directly related to estrogen dose and inversely related to progestin dose. '8 In the present study, the numbers were too small to permit firm conclusions regarding the effects of individual estrogens and progestins on the lipid fractions.
The occurrence of MI in OC users without angiographic evidence of atherosclerotic lesions19 raises the question of whether alterations in coagulation also play a role. OC users have been noted to have altered laboratory measurements of coagulation,'4, 20. 21 and increased rates of thromboembolic diseases." 6, 22, 23 Increased sensitivity of platelets to epinephrine has been described both in OC users20 and in familial hypertriglyceridemia. 24 The qualitative changes within each of the lipoprotein fractions with OC use need further clarification, as do effects of different OC preparations on various lipoprotein fractions. Finally, further data are necessary to quantitate possible interactions between OC use, other coronary risk factors and MI.
